Mid‐life and late‐life vascular risk factor burden and neuropathology in old age

Abstract Objective To determine whether vascular risk factor burden in mid‐ or late‐life associates with postmortem vascular and neurodegenerative pathologies in a community‐based sample. Methods We studied participants from the Framingham Heart Study who participated in our voluntary brain bank pro...

Full description

Bibliographic Details
Main Authors: Sarah C. Conner, Matthew P. Pase, Herman Carneiro, Mekala R. Raman, Ann C. McKee, Victor E. Alvarez, Jamie M. Walker, Claudia L. Satizabal, Jayandra J. Himali, Thor D. Stein, Alexa Beiser, Sudha Seshadri
Format: Article
Language:English
Published: Wiley 2019-12-01
Series:Annals of Clinical and Translational Neurology
Online Access:https://doi.org/10.1002/acn3.50936
_version_ 1819118813064462336
author Sarah C. Conner
Matthew P. Pase
Herman Carneiro
Mekala R. Raman
Ann C. McKee
Victor E. Alvarez
Jamie M. Walker
Claudia L. Satizabal
Jayandra J. Himali
Thor D. Stein
Alexa Beiser
Sudha Seshadri
author_facet Sarah C. Conner
Matthew P. Pase
Herman Carneiro
Mekala R. Raman
Ann C. McKee
Victor E. Alvarez
Jamie M. Walker
Claudia L. Satizabal
Jayandra J. Himali
Thor D. Stein
Alexa Beiser
Sudha Seshadri
author_sort Sarah C. Conner
collection DOAJ
description Abstract Objective To determine whether vascular risk factor burden in mid‐ or late‐life associates with postmortem vascular and neurodegenerative pathologies in a community‐based sample. Methods We studied participants from the Framingham Heart Study who participated in our voluntary brain bank program. Overall vascular risk factor burden was calculated using the Framingham Stroke Risk Profile (FSRP). Mid‐life FSRP was measured at 50 to 60 years of age. Following death, brains were autopsied and semi‐quantitatively assessed by board‐certified neuropathologists for cerebrovascular outcomes (cortical infarcts, subcortical infarcts, atherosclerosis, arteriosclerosis) and Alzheimer’s disease pathology (Braak stage, cerebral amyloid angiopathy, and neuritic plaque score). We estimated adjusted odds ratios between vascular risk burden (at mid‐life and before death) and neuropathological outcomes using logistic and proportional‐odds logistic models. Results The median time interval between FSRP and death was 33.4 years for mid‐life FSRP and 4.4 years for final FSRP measurement before death. Higher mid‐life vascular risk burden was associated with increased odds of all cerebrovascular pathology, even with adjustment for vascular risk burden before death. Late‐life vascular risk burden was associated with increased odds of cortical infarcts (OR [95% CI]: 1.04 [1.00, 1.08]) and arteriosclerosis stage (OR [95% CI]: 1.03 [1.00, 1.05]). Mid‐life vascular risk burden was not associated with Alzheimer’s disease pathology, though late‐life vascular risk burden was associated with increased odds of higher Braak stage (OR [95% CI]: 1.03 [1.01, 1.05]). Interpretation Mid‐life vascular risk burden was predictive of cerebrovascular but not Alzheimer’s disease neuropathology, even after adjustment for vascular risk factors before death.
first_indexed 2024-12-22T05:54:50Z
format Article
id doaj.art-82320af58984449f8dba3f30cff9e694
institution Directory Open Access Journal
issn 2328-9503
language English
last_indexed 2024-12-22T05:54:50Z
publishDate 2019-12-01
publisher Wiley
record_format Article
series Annals of Clinical and Translational Neurology
spelling doaj.art-82320af58984449f8dba3f30cff9e6942022-12-21T18:36:45ZengWileyAnnals of Clinical and Translational Neurology2328-95032019-12-016122403241210.1002/acn3.50936Mid‐life and late‐life vascular risk factor burden and neuropathology in old ageSarah C. Conner0Matthew P. Pase1Herman Carneiro2Mekala R. Raman3Ann C. McKee4Victor E. Alvarez5Jamie M. Walker6Claudia L. Satizabal7Jayandra J. Himali8Thor D. Stein9Alexa Beiser10Sudha Seshadri11Framingham Heart Study Framingham MassachusettsFramingham Heart Study Framingham MassachusettsFramingham Heart Study Framingham MassachusettsDepartment of Neurology Boston University School of Medicine Boston MassachusettsDepartment of Neurology Boston University School of Medicine Boston MassachusettsBoston University Alzheimer's Disease and CTE Center Boston University School of Medicine Boston MassachusettsGlenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases UT Health San Antonio San Antonio TexasFramingham Heart Study Framingham MassachusettsFramingham Heart Study Framingham MassachusettsBoston University Alzheimer's Disease and CTE Center Boston University School of Medicine Boston MassachusettsFramingham Heart Study Framingham MassachusettsFramingham Heart Study Framingham MassachusettsAbstract Objective To determine whether vascular risk factor burden in mid‐ or late‐life associates with postmortem vascular and neurodegenerative pathologies in a community‐based sample. Methods We studied participants from the Framingham Heart Study who participated in our voluntary brain bank program. Overall vascular risk factor burden was calculated using the Framingham Stroke Risk Profile (FSRP). Mid‐life FSRP was measured at 50 to 60 years of age. Following death, brains were autopsied and semi‐quantitatively assessed by board‐certified neuropathologists for cerebrovascular outcomes (cortical infarcts, subcortical infarcts, atherosclerosis, arteriosclerosis) and Alzheimer’s disease pathology (Braak stage, cerebral amyloid angiopathy, and neuritic plaque score). We estimated adjusted odds ratios between vascular risk burden (at mid‐life and before death) and neuropathological outcomes using logistic and proportional‐odds logistic models. Results The median time interval between FSRP and death was 33.4 years for mid‐life FSRP and 4.4 years for final FSRP measurement before death. Higher mid‐life vascular risk burden was associated with increased odds of all cerebrovascular pathology, even with adjustment for vascular risk burden before death. Late‐life vascular risk burden was associated with increased odds of cortical infarcts (OR [95% CI]: 1.04 [1.00, 1.08]) and arteriosclerosis stage (OR [95% CI]: 1.03 [1.00, 1.05]). Mid‐life vascular risk burden was not associated with Alzheimer’s disease pathology, though late‐life vascular risk burden was associated with increased odds of higher Braak stage (OR [95% CI]: 1.03 [1.01, 1.05]). Interpretation Mid‐life vascular risk burden was predictive of cerebrovascular but not Alzheimer’s disease neuropathology, even after adjustment for vascular risk factors before death.https://doi.org/10.1002/acn3.50936
spellingShingle Sarah C. Conner
Matthew P. Pase
Herman Carneiro
Mekala R. Raman
Ann C. McKee
Victor E. Alvarez
Jamie M. Walker
Claudia L. Satizabal
Jayandra J. Himali
Thor D. Stein
Alexa Beiser
Sudha Seshadri
Mid‐life and late‐life vascular risk factor burden and neuropathology in old age
Annals of Clinical and Translational Neurology
title Mid‐life and late‐life vascular risk factor burden and neuropathology in old age
title_full Mid‐life and late‐life vascular risk factor burden and neuropathology in old age
title_fullStr Mid‐life and late‐life vascular risk factor burden and neuropathology in old age
title_full_unstemmed Mid‐life and late‐life vascular risk factor burden and neuropathology in old age
title_short Mid‐life and late‐life vascular risk factor burden and neuropathology in old age
title_sort mid life and late life vascular risk factor burden and neuropathology in old age
url https://doi.org/10.1002/acn3.50936
work_keys_str_mv AT sarahcconner midlifeandlatelifevascularriskfactorburdenandneuropathologyinoldage
AT matthewppase midlifeandlatelifevascularriskfactorburdenandneuropathologyinoldage
AT hermancarneiro midlifeandlatelifevascularriskfactorburdenandneuropathologyinoldage
AT mekalarraman midlifeandlatelifevascularriskfactorburdenandneuropathologyinoldage
AT anncmckee midlifeandlatelifevascularriskfactorburdenandneuropathologyinoldage
AT victorealvarez midlifeandlatelifevascularriskfactorburdenandneuropathologyinoldage
AT jamiemwalker midlifeandlatelifevascularriskfactorburdenandneuropathologyinoldage
AT claudialsatizabal midlifeandlatelifevascularriskfactorburdenandneuropathologyinoldage
AT jayandrajhimali midlifeandlatelifevascularriskfactorburdenandneuropathologyinoldage
AT thordstein midlifeandlatelifevascularriskfactorburdenandneuropathologyinoldage
AT alexabeiser midlifeandlatelifevascularriskfactorburdenandneuropathologyinoldage
AT sudhaseshadri midlifeandlatelifevascularriskfactorburdenandneuropathologyinoldage